Thursday, May 9, 2002

Genentech Invites Investors to Listen to Webcast of May 21 Discussion of ASCO Presentations

South San Francisco, Calif. -- May 9, 2002 --

Genentech, Inc. (NYSE: DNA) invites investors and the general public to listen to a webcast of a discussion of oncology data presented at the American Society of Clinical Oncology (ASCO) in Orlando, FL.  The webcast will begin at 8:00 a.m. Eastern Time on May 21.  The live webcast can be accessed by going to Genentech's website at and will be archived and available for replay through close of business on May 28, 2002.

An audio replay of the webcast will be available beginning at 11:00 a.m. Eastern Time on May 21, 2002 through the close of business on May 28, 2002. Access numbers for this replay are: 1-800-642-1687 (U.S./Canada) and 1-706-645-9291 (international); passcode  number is 4135218.

Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes biotherapeutics for significant unmet medical needs.  Fifteen of the currently approved biotechnology products stem from or are based on Genentech science.  Genentech manufactures and commercializes ten biotechnology products directly in the United States.  The company has headquarters in South San Francisco, California, and is traded on the New York Stock Exchange under the symbol DNA.


# # #